What Is Hemophilia A?

It is a bleeding disorder caused by a shortage of factor VIII, a protein your blood needs to form a clot. It is the more common of the two conditions, affecting roughly 1 in every 5,000 male births.

Type A almost always passes from parent to child through a gene on the X chromosome, which is why it shows up mostly in boys and men. A mother who carries the faulty gene usually has no symptoms herself but can still pass it to her sons.

What Is Hemophilia B?

It is the same basic problem as type A: a clotting protein is missing, except here the missing protein is factor IX rather than factor VIII. It is also known as Christmas disease, named after the first patient studied with this condition rather than the holiday.

B is rarer, affecting roughly 1 in every 30,000 male births, which makes it about five to six times less common than A. It follows the same inheritance pattern, passed down through a gene on the X chromosome.

Hemophilia A vs B: The Core Difference at a Glance

Here is the simplest way to see hemophilia A vs B side by side:

The one column that actually changes daily care is desmopressin. This nasal spray or injection can boost fac. VIII levels in mild Type A cases, sometimes avoiding a infusion altogether. It does nothing for Type B, since fac. IX is not the protein it triggers.

Hemophilia A and B Symptoms: Why They Look Identical

Hemophilia A and B symptoms are close to indistinguishable without a blood test, since both conditions share the same underlying problem: blood that takes too long to clot. Common signs include:

• Bruising easily, even from minor bumps
• Bleeding for a long time after a cut, dental work, or surgery
• Joint pain, swelling, or warmth from bleeding inside a joint, most often the knees, elbows, or ankles
• Unexplained nosebleeds or blood in urine or stool
• In babies, large bruises or stiffness once they start crawling or walking.

The severity of these symptoms depends on the same scale for both types. Less than 1 percent of normal factor activity is severe, 1 to 5 percent is moderate, and 5 to 40 percent is mild. A child with severe Type A and a child with severe Type B can look almost the same in a clinic, both with frequent joint bleeds and a need for regular preventive treatment.

One subtle difference researchers have noted: people with severe Type B tend to bleed slightly less often than those with severe Type A, and need joint replacement surgery less frequently. The reason is not fully settled, but it means Type B may run a touch milder at the same severity level, even though both are still treated as serious, lifelong conditions.

Difference Between Hemophilia A and B in Treatment

The difference between type A and B that matters most for day-to-day care is which factor concentrate a patient receives. A is treated with fac. VIII replacement, given as an infusion either regularly to prevent bleeds or immediately after a bleed. B is treated with fac. IX replacement instead, following the same general schedule.

Newer non-factor treatments, such as the injectable drug emicizumab, currently work only for A. Gene therapy is now approved for both types, though the specific products differ because each targets a different gene.
<h3class=”blogs_heading”>How Doctors Tell the Two Apart?

Since the bleeding pattern looks the same, diagnosis depends entirely on lab work, not symptoms. The standard path is:

• Clotting time test: A prolonged result flags a likely clotting factor problem but does not say which one.
• Specific factor assay: A blood test measures factor VIII and IX activity directly, which is the only way to confirm whether it is type A or B and how severe it is.
• Genetic testing: Identifies the exact mutation, which helps with family planning and carrier testing for female relatives.

Getting the type right matters beyond labeling. The wrong factor replacement will not stop a bleed, since each product only restores one specific protein.

FAQ